Advertisement
Advertisement
OSRH
OSR Health, Inc. Common Stock
0.41
USDSponsored
-0.03
-7.31%
Aug 10, 15:59 UTC -4
Closed
After-Market
0.41
0.00
-0.15%
OSRH Earnings Reports
Positive Surprise Ratio
OSRH beat 1 of 2 last estimates.
50%
Next Report
In 2 Days
Date of Next Report
Aug 12, 2026
Estimate for Q2 26 (Revenue/ EPS)
$793.56K
/-$0.28
Implied change from Q1 26 (Revenue/ EPS)
--
/--
Implied change from Q2 25 (Revenue/ EPS)
--
/--
OSR Health, Inc. Common Stock earnings per share and revenue
On May 18, 2026, OSRH reported earnings of -- USD per share (EPS) for Q1 26, -- the estimate of -0.29 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 793.56 thousand, with a --% difference.
Looking ahead to Q2 26, -- analysts forecast an EPS of -0.28 USD, with revenue projected to reach 793.56 thousand USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Passage Bio, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$2.69
Actual
-$2.44
Surprise
+9.62%
Axsome Therapeutics, Inc
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.86
Actual
-$0.99
Surprise
-14.90%
Apogee Therapeutics, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$1.09
Actual
-$1.13
Surprise
-4.39%
Biohaven Ltd.
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.74
Actual
-$0.91
Surprise
-21.67%
Septerna, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.43
Actual
-$0.28
Surprise
+33.26%
Olema Pharmaceuticals, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.55
Actual
-$0.61
Surprise
-9.83%
Sana Biotechnology, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.14
Actual
-$0.13
Surprise
+12.58%
Enanta Pharmaceuticals, Inc
Report Date
Aug 10, 2026 For Q3 26
Estimate
-$0.52
Actual
-$0.67
Surprise
-28.80%
Orchestra BioMed Holdings, Inc. Ordinary Shares
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.39
Actual
-Surprise
-
Entera Bio Ltd. Ordinary Shares
Report Date
Aug 07, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.14
Surprise
-71.57%
FAQ
What were OSR Health, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, OSR Health, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to OSR Health, Inc. Common Stock's Q1 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is OSR Health, Inc. Common Stock expected to report next?
The next earning report is scheduled for Aug 12, 2026.
What are the forecasts for OSR Health, Inc. Common Stock's next earnings report?
Based on --
analysts, OSR Health, Inc. Common Stock is expected to report EPS of -$0.28 and revenue of $793.56K for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement